Anthera Pharmaceuticals, Inc.
ANTH
$0.0001
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Net Income | 57.47% | 51.60% | 39.48% | 9.77% | -40.01% |
| Total Depreciation and Amortization | 66.11% | 5.64% | -13.42% | 11.68% | -17.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -224.68% | -205.39% | -222.53% | -181.53% | 33.85% |
| Change in Net Operating Assets | 39.50% | -475.50% | -403.36% | -993.10% | -2,001.89% |
| Cash from Operations | 39.19% | 24.57% | 7.10% | -27.73% | -50.13% |
| Capital Expenditure | -- | -- | 119.54% | 84.29% | -994.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 146.74% | -- | 119.54% | 84.29% | -994.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -1.11% | 171.10% | 132.88% | -49.13% | -38.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -99.53% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.27% | -22.58% | -32.28% | 0.57% | 15.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.05% | 28.58% | -14.24% | -149.45% | -356.78% |